Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Pliant Therapeutics (PLRX) Interest Expenses (2022 - 2025)

Historic Interest Expenses for Pliant Therapeutics (PLRX) over the last 4 years, with Q3 2025 value amounting to $815000.0.

  • Pliant Therapeutics' Interest Expenses fell 706.96% to $815000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 million, marking a year-over-year increase of 2970.93%. This contributed to the annual value of $3.0 million for FY2024, which is 13867.4% up from last year.
  • According to the latest figures from Q3 2025, Pliant Therapeutics' Interest Expenses is $815000.0, which was down 706.96% from $809000.0 recorded in Q2 2025.
  • Pliant Therapeutics' Interest Expenses' 5-year high stood at $877000.0 during Q3 2024, with a 5-year trough of $173000.0 in Q2 2022.
  • For the 4-year period, Pliant Therapeutics' Interest Expenses averaged around $536142.9, with its median value being $383000.0 (2023).
  • Its Interest Expenses has fluctuated over the past 5 years, first surged by 17665.62% in 2024, then tumbled by 706.96% in 2025.
  • Pliant Therapeutics' Interest Expenses (Quarter) stood at $317000.0 in 2022, then rose by 1.26% to $321000.0 in 2023, then skyrocketed by 159.81% to $834000.0 in 2024, then dropped by 2.28% to $815000.0 in 2025.
  • Its last three reported values are $815000.0 in Q3 2025, $809000.0 for Q2 2025, and $799000.0 during Q1 2025.